Osmotica Pharmaceutical Corp. Revenue and Competitors
Estimated Revenue & Valuation
- Osmotica Pharmaceutical Corp.'s estimated annual revenue is currently $165.9M per year.
- Osmotica Pharmaceutical Corp.'s estimated revenue per employee is $11,850,000
- Osmotica Pharmaceutical Corp.'s current valuation is $94.1M. (January 2022)
Employee Data
- Osmotica Pharmaceutical Corp. has 14 Employees.
- Osmotica Pharmaceutical Corp. grew their employee count by -22% last year.
Osmotica Pharmaceutical Corp.'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | QMS Manager | Reveal Email/Phone |
2 | Deviation Writer | Reveal Email/Phone |
Osmotica Pharmaceutical Corp. Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Osmotica Pharmaceutical Corp.?
Osmotica Pharmaceutical is a fully-integrated pharmaceutical company with demonstrated expertise in developing commercially successful products. As one of the world's leading osmotic drug delivery companies, we leverage our significant resources in R&D and proprietary drug delivery technology to address the growing need of the global patient population. We have the resources and experience to successfully commercialize our products through our subsidiaries, Vertical Pharmaceuticals, LLC and Trigen Laboratories, LLC. For more company information, please visit our websites: www.Osmotica.com www.VerticalPharma.com www.TrigenLab.com
keywords:Biotechnology,Healthcare,Pharmaceuticals
N/A
Total Funding
14
Number of Employees
$165.9M
Revenue (est)
-22%
Employee Growth %
$94.1M
Valuation
N/A
Accelerator
Osmotica Pharmaceutical Corp. News
BRIDGEWATER, N.J., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, today announced that on October 12, 2021, it closed its previously announced underwritten public offering of 14,000,000 ordinary sha ...
BRIDGEWATER, N.J., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, today announced that on October 12, 2021, it closed its previously announced underwritten public offering of 14,000,000 ordinary sha ...
BRIDGEWATER, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, today announced the pricing of its previously announced underwritten public offering of 14,000,000 ordinary shares of the Company an ...
Other Companies in Bridgewater
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $165.9M | 14 | -22% | N/A |
#2 | $1.2M | 14 | 8% | N/A |
#3 | $1.3M | 15 | 25% | N/A |
#4 | $1.3M | 15 | 7% | N/A |
#5 | $4.3M | 17 | -45% | N/A |